Literature DB >> 23097118

Primary culture and propagation of human prostate epithelial cells.

Birunthi Niranjan1, Mitchell G Lawrence, Melissa M Papargiris, Michelle G Richards, Shirin Hussain, Mark Frydenberg, John Pedersen, Renea A Taylor, Gail P Risbridger.   

Abstract

Basic and translational (or preclinical) prostate cancer research has traditionally been conducted with a limited repertoire of immortalized cell lines, which have homogeneous phenotypes and have adapted to long-term tissue culture. Primary cell culture provides a model system that allows a broader spectrum of cell types from a greater number of patients to be studied, in the absence of artificially induced genetic mutations. Nevertheless, primary prostate epithelial cell culture can be technically challenging, even for laboratories experienced in immortalized cell culture. Therefore, we provide methods to isolate and culture primary epithelial cells directly from human prostate tissue. Initially, we describe the isolation of bulk epithelial cells from benign or tumor tissues. These cells have a predominantly basal/intermediate phenotype and co-express cytokeratin 8/18 and high molecular weight cytokeratins. Since prostatic stem cells play a major role in disease progression and are considered to be a therapeutic target, we also describe a prospective approach to specifically isolate prostatic basal cells that include both stem and transit-amplifying basal populations, which can be studied independently or subsequently differentiated to supply luminal cells. This approach allows the study of stem cells for the development of new therapeutics for prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23097118     DOI: 10.1007/978-1-62703-125-7_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Identification of multipotent luminal progenitor cells in human prostate organoid cultures.

Authors:  Wouter R Karthaus; Phillip J Iaquinta; Jarno Drost; Ana Gracanin; Ruben van Boxtel; John Wongvipat; Catherine M Dowling; Dong Gao; Harry Begthel; Norman Sachs; Robert G J Vries; Edwin Cuppen; Yu Chen; Charles L Sawyers; Hans C Clevers
Journal:  Cell       Date:  2014-09-04       Impact factor: 41.582

2.  Enduring epigenetic landmarks define the cancer microenvironment.

Authors:  Ruth Pidsley; Mitchell G Lawrence; Gail P Risbridger; Susan J Clark; Elena Zotenko; Birunthi Niranjan; Aaron Statham; Jenny Song; Roman M Chabanon; Wenjia Qu; Hong Wang; Michelle Richards; Shalima S Nair; Nicola J Armstrong; Hieu T Nim; Melissa Papargiris; Preetika Balanathan; Hugh French; Timothy Peters; Sam Norden; Andrew Ryan; John Pedersen; James Kench; Roger J Daly; Lisa G Horvath; Phillip Stricker; Mark Frydenberg; Renea A Taylor; Clare Stirzaker
Journal:  Genome Res       Date:  2018-04-12       Impact factor: 9.043

Review 3.  Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects.

Authors:  Sander Frank; Peter Nelson; Valeri Vasioukhin
Journal:  F1000Res       Date:  2018-08-02

Review 4.  Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies.

Authors:  Anastasia C Hepburn; C H Cole Sims; Adriana Buskin; Rakesh Heer
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

5.  Decellularized In Vitro Capillaries for Studies of Metastatic Tendency and Selection of Treatment.

Authors:  Outi Huttala; Desiree Loreth; Synnöve Staff; Minna Tanner; Harriet Wikman; Timo Ylikomi
Journal:  Biomedicines       Date:  2022-01-26

6.  Organoid culture systems for prostate epithelial and cancer tissue.

Authors:  Jarno Drost; Wouter R Karthaus; Dong Gao; Else Driehuis; Charles L Sawyers; Yu Chen; Hans Clevers
Journal:  Nat Protoc       Date:  2016-01-21       Impact factor: 13.491

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.